Treatment of chronic hepatitis C in children

Pediatric Transplantation

Volumn 8, Issue 6, 2004, Pages 639-643

  González Peralta, Regino P ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Children; Hepatitis C; Interferon; Ribavirin; Treatment

Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON; RIBAVIRIN;

ANEMIA; ANOREXIA; CONFERENCE PAPER; DEPRESSION; FATIGUE; FLU LIKE SYNDROME; HEPATITIS; HEPATITIS C; HUMAN; LEUKOPENIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; RNA VIRUS; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LIVER DISEASES; LIVER TRANSPLANTATION; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL;

EID: 11144244762     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00250.x     Document Type: Conference Paper

References (39)

1. ROBERTSON B, MYERS G, HOWARD C, et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. Arch Virol 1998: 143: 2493-2503.
2. THOMSON M, LIANG TJ. Molecular biology of hepatitis C virus. In: LIANG TJ, HOOFNAGLE JH, eds. Hepatitis C. San Diego, California: Academic Press, 2000.
3. SMITH RM, WU GY. Molecular virology of hepatitis B and C. In: KOFF RS, WU GY, eds. Chronic Viral Hepatitis: Diagnosis and Therapeutics. Totowa, New Jersey: Humana Press, 2002.
4. WALEWSKI JL, KELLER TR, STUMP DD, BRANCH AD. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 2001: 7: 710-721.
5. LAU JYN, DAVIS GL, PRESCOTT LE, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 1996: 124: 868-876.
6. JARA P, RESTI M, HIERRO L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clinical Infect Dis 2003: 36: 275-280.
7. GONZÁLEZ-PERALTA RP, HABER B, JONAS M, et al. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children. Hepatology 2002: 36: 311A.
8. JACOBSON KR, MURRAY K, ZELLOS A and SCHWARZ KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol and Nutr 2002: 34: 52-58.
9. MATSUOKA S, TATARA K, HAYABUCHI Y, et al. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics 1994: 94: 919-922.
10. GARCIA-MONZON C, JARA P, FERNANDEZ-BERMEJO M, et al. Chronic hepatitis C in children: A clinical and immunohistochemical comparative study with adults patients. Hepatology 1998: 28: 1696-1701.
11. YEUNG LTF, KING SM, ROBERTS EA. Mother-to-infant transmission of hepatitis C virus. Hepatology 2001: 34: 223-229.
12. SCHREIBER GB, BUSCH MP, KLEINMAN SH, et al. The risk of transfusion-transmitted viral infections. N Engl J Med 1996: 334: 1685-1690.
13. CHESNEY PJ, FISHER MC, GERBER MA, et al. Hepatitis C virus infection. Pediatrics 1998: 101: 481-485.
14. JONAS M. Children with Hepatitis C. Hepatology 2002: 36: S173-S178.
15. PALOMBA E, MANZINI P, FIAMMENGO P, et al. Natural history of perinatal hepatitis C virus infection. Clin Infect Dis 1996: 23: 47-50.
16. BORTOLOTTI F, RESTI M, GIACCHINO R, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997: 130: 990-993.
17. TOVO P-A, PEMBREY LJ, NEWELL M-L. Persistence rate and progression of vertically acquired hepatitis C infection. J Infect Dis 2000: 181: 419-424.
18. RESTI M, JARA P, HIERRO L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003: 70: 373-377.
19. NI YH, CHANG MH, LUE HC, et al. Posttransfusion hepatitis C infection in children. Pediatrics 1994: 124: 709-713.
20. VOGT M, LANG T, FROSNER G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999: 341: 866-870.
21. CASIRAGHI MA, DE PASCHALE M, ROMANÒ L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004: 39: 90-96.
22. SASAKI N, MATSUI A, MOMOI M, et al. Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission. Pediatr Res 1997: 42: 263-267.
23. STRICKLAND DK, JENKINS JJ, HUDSON MM. Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer. J Pediatr Hematol Oncol 2001: 23: 527-529.
24. GONZÁLEZ-PERALTA RP, LANGHAM MR, MOHAN P, et al. Hepatocellular carcinoma in two adolescents with cirrhosis secondary to hepatitis C virus infection. J Pediatr Gastroenterol Nutr 2003: 37: 380 (Abstract).
25. DAVIS GL. Treatment of acute and chronic hepatitis C. Clin Liver Dis 1997: 1: 615-630.
26. LAU JY, TAM RC, LIANG TJ, HONG Z. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology 2002: 35: 1002-1009.
27. DAVIS GL, ESTEBAN-MUR R, RUSTGI V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998: 339: 1493-1499.
28. MCHUTCHISON JG, GORDON SC, SCHIFF ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998: 339: 1485-1492.
29. KELLY DA, BUNN SK, APELIAN D, et al. Safety, efficacy and Pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C. Hepatology 2001: 34: 680A (Abstract).
30. LACKNER H, MOSER A, DEUTSCH J, et al. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000: 106: E53-E56.
31. CHRISTENSSON B, WIEBE T, AKESSON A, WIDELL A. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis 2000: 30: 585-586.
32. WIRTH S, LANG T, GEHRING S, GERNER P. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002: 36: 1280-1284.
33. IORIO R, PENSATI P, BOTTA S, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997: 16: 984-990.
34. FRIED MW, SHIFFMAN ML, REDDY KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002: 347: 975-982.
35. MANNS MP, MCHUTCHISON JG, GORDON SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet. 2001: 22: 958-965.
36. SCHWARZ KB, MOHAN P, NARKEWICZ M, et al. The safety, efficacy and pharmacokinetics of peginterferon alfa-2a (40 kD) in children with chronic hepatitis C. Gastroenterology 2003: 124: A700.
37. BERENGUER M, WRIGHT TL. Treatment strategies for hepatitis C: Intervention prior to liver transplant, pre-emptively or after established disease. Clin Liver Dis 2003: 7: 631-650.
38. NOWICKI MJ, AHMAD N, HEUBI JE, et al. The prevalence of hepatitis C virus (HCV) in infants and children after liver transplantation. Dig Sis Sci 1994: 39: 2250-2254.
39. MCDIARMID SV, CONRAD A, AMENT ME, et al. De novo hepatitis C in children after liver transplantation. Transplantation 1998: 66: 311-318.